Highlights of ACC 2024
Cardiology Update
APRIL 9, 2024
The percent change from baseline in fasting triglycerides (TG) at six months served as the primary outcome measure. The percent change from baseline in fasting TG at six months served as the primary outcome measure. A total of 716 patients underwent TAVR with either a self-expanding supraannular valve or a balloon-expandable valve.
52 
Let's personalize your content